Stamford, CT -- (SBWIRE) -- 01/22/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Best Buy Co., Inc.(NYSE:BBY), ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC), Galena Biopharma Inc(NASDAQ:GALE), Cannabis Science Inc(OTCMKTS:CBIS)
Best Buy Co., Inc.(NYSE:BBY) opened the session at $24.59, remained amid the day range of $24.25 - $25.09, and closed the session at $24.47. The stock showed a positive performance of +0.16% in previous trading session. The stock gained a volume of 24.89 million shares and the average volume of the stock remained 9.91 million shares. Best Buy Co., Inc. operates as an e-commerce and physical retailer of consumer electronics in the United States, Europe, Canada, and China.
Why Should Investors Buy BBY After The Recent Gain? Just Go Here and Find Out
ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) traded with volume of 18.79 million shares in the prior session and the average volume of the stock remained 4.27 million shares. The 52 week range of the stock remained $0.65 - $4.00. The stock showed a positive movement of +32.76% and closed its session at $1.54. The market capitalization of the stock remained 87.93 million. mmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, engages in developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumors.
Will IMUC Continue To Move Higher? Find Out Here
Galena Biopharma Inc(NASDAQ:GALE) exchanged 20.09 million shares and the average volume remained 7.86 million shares. The stock dropped -8.86% and closed the session at $6.38. The beta of the stock remained 1.11 and the EPS of the stock remained -0.38. The shares outstanding of the stock remained 105.24 million. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care.
Has GALE Found The Bottom And Ready To Gain Momentum? Find Out Here
Cannabis Science Inc(OTCMKTS:CBIS) gained volume of 36.05 million shares, while the average volume remained 30.16 million shares. The stock advanced +12.38% and finished the session Tuesday at $0.113. The EPS of the stock remained -0.01. The one month of the stock was 291.38% and three month trend remained positive 187.34%. Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.
For How Long CBIS’s Gloss will Attract Investors ? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)